Deals: Page 88
-
Lilly, Yabao develop, market diabetes drug
The combined capabilities will give the two a presence in China and global reach.
By Nicole Gray • July 8, 2014 -
Hedge fund nominates Allergan slate as takeover fight escalates
The Botox manufacturer scoffs at claims the nominees are independent of the two suitors.
By Nicole Gray • July 8, 2014 -
Deep Dive
Valeant may have antidote for Allergan's 'poison pill'
Ultimately, the issue might be resolved by a boardroom fight.
By Nicole Gray • July 7, 2014 -
Jazz Pharmaceuticals acquires North, South American rights to defibrotide
The company continues to bolster its clinical and commercial expertise in the fields.
By Nicole Gray • July 3, 2014 -
ANI plans immediate launch of Lithobid
The company is expecting immediate sales revenues approaching $4 million as it builds a mature brands portfolio.
By Nicole Gray • July 3, 2014 -
Quintiles acquires Encore Health Services
The acquisition underscores the value of informatics expertise.
By Nicole Gray • July 3, 2014 -
Carlyle Group buys diagnostics business from J&J
With the acquisition, the private equity investment firm becomes a bigger player in the biopharma space.
By Nicole Gray • July 3, 2014 -
Transcept and Paratek Pharma to merge
Investors infuse more capital to support development of the company’s lead antibiotic candidate.
By Nicole Gray • July 2, 2014 -
Cidara Therapeutics completes $32 million financing for immunotherapy research
The company wants to change the standard of care for invasive fungal infections.
By Nicole Gray • July 1, 2014 -
CHMP recommends Eliquis for recurrent thrombotic events
Positive response was based on clinical data on almost 8,000 patients who had experienced a previous thrombotic event.
By Nicole Gray • June 30, 2014 -
Roche making $5 million milestone payment to Halozyme
The payment for the two companies' MabThera SC collaboration comes as the drug is launched in Europe.
By Nicole Gray • June 30, 2014 -
Shire prevails in patent suit, gains traction against AbbVie takeover bid
The ruling could help Shire in its ongoing battle.
By Nicole Gray • June 26, 2014 -
Valeant pursuing shareholder support in Allergan bid
Its takeover effort turns more aggressive.
By Nicole Gray • June 26, 2014 -
Melanoma drug trial stopped early after positive results
The decision could cheer Bristol-Myers Squibb stockholders -- and the medical community.
By Nicole Gray • June 25, 2014 -
Bayer, Dimension Therapeutics collaborating on hemophilia A gene therapy
If the treatment makes it to market, it will be a major game-changer for patients.
By Nicole Gray • June 25, 2014 -
Inovio initiates early-stage clinical trials for cervical cancer drug
The candidate is part of the emerging class of immuno-oncologic drugs.
By Nicole Gray • June 25, 2014 -
Sanofi, Merrimack continue development of molecular target found in many cancers
An extensive phase II clinical trial program is underway.
By Nicole Gray • June 22, 2014 -
Companies collaborate to fight multidrug-resistant pathogens
A new diagnostic test is available in Europe and coming to the U.S., but that's just the first step.
By Nicole Gray • June 22, 2014 -
J&J rachets up R&D through 12 new alliances
The company has many collaborations underway.
By Nicole Gray • June 20, 2014 -
Pfizer expands immuno-oncology research through Cellectics parnership
Pfizer is expanding oncology research by collaborating with Cellectics, which brings a unique immuno-oncology research platform to the partnership.
By Nicole Gray • June 19, 2014 -
Pfizer expands research capacity with Cambridge, MA location
The firm is setting up a mega-research facility, bringing together industry, academic and the hospital system to collaborate on therapeutic innovation.
By Nicole Gray • June 18, 2014 -
JNJ partners with Viiv to create new combo HIV drug
The medication could end up rivaling Atripla.
By Nicole Gray • June 17, 2014 -
Sanofi, Medtronic team up to offer options for diabetes patients
The new partnership focuses on innovative drug-device breakthroughs.
By Nicole Gray • June 17, 2014 -
Medtronic buying Ireland-based Covidien
The merger will make Medtronic a mega-medical-device company.
By Nicole Gray • June 16, 2014 -
NICE reverses stance on skin cancer treatment after reviewing new survival data
The panel changed its decision of four months ago based on positive survival data extending out three years.
By Nicole Gray • June 16, 2014
Previous
